← FDA Drug Approvals (Drugs@FDA)

TAZICEF

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1986-03-06

Drug application

FDA Application #

ANDA062662

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAZICEF

Generic name

CEFTAZIDIME

Active ingredients

CEFTAZIDIME

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

1986-03-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown